首页|含钙置换液在局部枸橼酸抗凝连续性肾脏替代治疗中的疗效和安全性研究

含钙置换液在局部枸橼酸抗凝连续性肾脏替代治疗中的疗效和安全性研究

扫码查看
目的 比较含钙置换液和无钙置换液在局部枸橼酸抗凝(RCA)连续性肾脏替代治疗(CRRT)中的疗效及安全性.方法 选取于徐州医科大学附属医院急诊重症监护病房(EICU)接受RCA的CRRT患者78例,采用随机数字表法分为含钙置换液组(含钙组,41例)和无钙置换液组(无钙组,37例).两组患者均采用连续性静脉透析滤过后稀释治疗模式,含钙组使用含钙置换液,无钙组使用无钙置换液,两组患者的抗凝方案及葡萄糖酸钙、钾离子补充方式均相同.记录并比较两组患者基线资料[年龄、性别比、病因、急性生理学与慢性健康状况评价Ⅱ(APACHE Ⅱ)、序贯器官衰竭评分(SOFA)及相关实验室检查指标],血滤器使用寿命、更换血滤器原因,CRRT后1、4、8、16、24、48、72h血清钙离子浓度及滤器后钙离子浓度,置管方式、撤机前跨膜压、血流速、置换液流速、透析液流速、治疗剂量、滤过分数、枸橼酸钠使用量及葡萄糖酸钙使用量,肾功能恢复率、EICU住院时间、28 d病死率及并发症发生率.结果 两组患者基线资料差异无统计学意义(均P>0.05).两组患者血滤器使用寿命、更换血滤器原因差异均无统计学意义(均P>0.05).含钙组患者葡萄糖酸钙使用量低于无钙组(P<0.05).两组患者置管方式、撤机前跨膜压、血流速、置换液流速、透析液流速、治疗剂量、滤过分数及枸橼酸钠使用量差异均无统计学意义(均P>0.05).CRRT后8、24 h无钙组患者血清钙离子浓度高于含钙组(均P<0.05),CRRT后1、4、16、48、72h两组患者血清钙离子浓度差异均无统计学意义(均P>0.05);CRRT后1、48、72h含钙组患者滤器后钙离子浓度高于无钙组(均P<0.05),CRRT后4、8、16、24h两组患者滤器后钙离子浓度差异无统计学意义(均P>0.05).两组患者肾功能恢复率、EICU住院时间、28 d病死率、并发症发生率差异均无统计学意义(均P>0.05).结论 基于RCA的CRRT采用含钙置换液与无钙置换液具有相似的疗效和安全性;含钙置换液能够显著减少葡萄糖酸钙的使用量,减少手工配置无钙置换液带来的相关风险,更有利于简化临床治疗流程.
Efficacy and safety of calcium-containing replacement solution in continuous renal replacement therapy with regional citrate anticoagulation
Objective To compare the efficacy and safety of calcium-containing replacement solution versus calcium-free re-placement solution in continuous renal replacement therapy(CRRT)with regional citrate anticoagulation(RCA).Methods A total of 78 CRRT patients receiving RCA in the emergency intensive care unit(EICU)of the Affiliated Hospital of Xuzhou Medical Universi-ty were selected.According to the random number table method,they were divided into two groups:a calcium-containing replacement solution group(a calcium group,n=41)and a calcium-free replacement solution group(a calcium-free group,n=37).Both groups re-ceived post-dilution continuous veno-venous hemodiafiltration therapy.The calcium group used calcium-containing replacement solu-tion,while the calcium-free group used calcium-free replacement solution.The anticoagulation regimen and methods for calcium gluco-nate and potassium ion supplementation were the same in both groups.Both groups were compared for baseline data:age,gender ratio,etiology,Acute Physiology and Chronic Health Evaluation Ⅱ(APACHE Ⅱ)score,Sequential Organ Failure Assessment(SOFA)score,and relevant laboratory indicators.The lifespan of hemofilters and reasons for their replacement were recorded.Serum calcium ion con-centrations and post-filter calcium ion concentrations were measured at post-CRTT 1,4,8,16,24,48 h,and 72 h.Both groups were compared for catheterization methods,transmembrane pressure before machine withdrawal,blood flow rate,replacement fluid flow rate,dialysate flow rate,treatment dose,filtration fraction,sodium citrate dosage,and calcium gluconate dosage.Their renal function recov-ery rate,the length of EICU stay,28-day mortality rate,and incidence of complications were also recorded.Results There were no statistical differences in baseline data between the two groups(all P>0.05).The lifespan of hemofilters and reasons for their replace-ment did not differ significantly(all P>0.05).The calcium group had a significantly lower dosage of calcium gluconate compared with the calcium-free group(P<0.05).No statistical differences were found between the groups in catheterization methods,transmembrane pressure before machine withdrawal,blood flow rate,replacement fluid flow rate,dialysate flow rate,treatment dose,filtration fraction,and sodium citrate dosage(all P>0.05).At post-CRRT 8 h and 24 h,the serum calcium ion concentrations were significantly higher in the calcium-free group than in the calcium group(both P<0.05).No statistical differences in serum calcium ion concentrations were ob-served at post-CRRT 1,4,16,48 h,and 72 h(all P>0.05).At post-CRRT 1,48 h,and 72 h,the post-filter calcium ion concentrations were significantly higher in the calcium group than the calcium-free group(all P<0.05).No significant differences were found at post-CRRT 4,8,16 h,and 24 h(all P>0.05).There were no statistical differences between the two groups in renal function recovery rate,the length of EICU stay,28-day mortality rate,or incidence of complications(all P>0.05).Conclusions In RCA-based CRRT,the use of calcium-containing replacement solution and calcium-free replacement solution can exhibit similar efficacy and safety.Calcium-containing replacement solution significantly reduces the dosage of calcium gluconate,decreases the risks associated with manually preparing calcium-free replacement solution,and helps simplify clinical treatment procedures.

Calcium-containing replacement solutionContinuous renal replacement therapyRegional citrate anticoagulation

邱小松、薛婷、叶英、燕宪亮、许铁

展开 >

徐州医科大学研究生院,徐州 221004

徐州医科大学附属医院急诊医学科,徐州 221002

睢宁县人民医院急诊医学科,徐州 221200

江苏省卫生应急研究所,徐州 221002

展开 >

含钙置换液 连续性肾脏替代治疗 局部枸橼酸抗凝

2024

国际麻醉学与复苏杂志
中华医学会,徐州医学院

国际麻醉学与复苏杂志

CSTPCD
影响因子:0.909
ISSN:1673-4378
年,卷(期):2024.45(11)